Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

NCT00387699 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: cisplatin
DRUG: etoposide
RADIATION: radiation therapy

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]